Patient characteristics, protocols and cost-effectiveness results for Oncotype DX per cycle.

Table B1. Distribution of sick leave for working patients. Table B2. ART-Patients characteristics. Table B3. Average dosage of chemotherapy drug per cycle in mg/m² per protocol. Table B4. Patient characteristics by hospital. Table B5. Distribution of side effects per cycle. Table B6. Home care. Table B7. Hospitalization characteristics. Table B8. Income for hospital per cycle. Table B9. Income for hospital by patient. Table B10. Aggregated costs per patient–Insurance perspective. Table B11. Aggregated costs per cycle–Insurance perspective. Table B12. Monitoring–Distribution of cycle with laboratory tests. Table B13. Monitoring–Consultation per cycle. Table B14. Pre-chemotherapy tests. Table B15. Protocols–Number of cycles. Table B16. Average cost by patient–Societal perspective. Table B17. Average cost per cycle–Societal perspective. Table B18. Distribution of chemotherapy strategies and protocols. Table B19. Distribution of cycle and reason for symptomatic prescription. Table B20. Transportation and distribution of transport. (RTF)